[The effect of pefloxacin on the chemotactic response of human polynuclear neutrophils after oral treatment]. 1987

J Y Lombard, and J Descotes, and A Eyraud, and J C Evreux

UI MeSH Term Description Entries
D008297 Male Males
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D009643 Norfloxacin A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE. AM-0715,AM-715,MK-0366,MK-366,MK0366,MK366,Noroxin,AM 0715,AM 715,AM0715,MK 0366,MK 366
D002634 Chemotaxis, Leukocyte The movement of leukocytes in response to a chemical concentration gradient or to products formed in an immunologic reaction. Leukotaxis,Leukocyte Chemotaxis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D015366 Pefloxacin A synthetic broad-spectrum fluoroquinolone antibacterial agent active against most gram-negative and gram-positive bacteria. 2589 R.B.,Abactal,Peflacine,Pefloxacin Mesylate,Pefloxacin Mesylate Dihydrate,Pefloxacine,Silver Pefloxacin,Dihydrate, Pefloxacin Mesylate,Mesylate Dihydrate, Pefloxacin,Mesylate, Pefloxacin,Pefloxacin, Silver,R.B., 2589

Related Publications

J Y Lombard, and J Descotes, and A Eyraud, and J C Evreux
December 1989, American journal of respiratory cell and molecular biology,
J Y Lombard, and J Descotes, and A Eyraud, and J C Evreux
July 1973, Infection and immunity,
J Y Lombard, and J Descotes, and A Eyraud, and J C Evreux
August 1976, Journal of immunology (Baltimore, Md. : 1950),
J Y Lombard, and J Descotes, and A Eyraud, and J C Evreux
January 2001, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
J Y Lombard, and J Descotes, and A Eyraud, and J C Evreux
January 1985, Annales de medecine interne,
J Y Lombard, and J Descotes, and A Eyraud, and J C Evreux
August 1989, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
J Y Lombard, and J Descotes, and A Eyraud, and J C Evreux
June 1993, Nouvelle revue francaise d'hematologie,
J Y Lombard, and J Descotes, and A Eyraud, and J C Evreux
January 1988, Microbiology and immunology,
J Y Lombard, and J Descotes, and A Eyraud, and J C Evreux
January 1987, Nouvelle revue francaise d'hematologie,
J Y Lombard, and J Descotes, and A Eyraud, and J C Evreux
January 1991, Annales de biologie clinique,
Copied contents to your clipboard!